First Tracks Biotherapeutics, Inc. Share Price
NASDAQ: TRAXFirst Tracks Biotherapeutics, Inc. Stock Performance
First Tracks Biotherapeutics, Inc. Share Price Today
As of 10 November 2026, First Tracks Biotherapeutics, Inc.'s share price is $49.68. The stock opened at $49.00, compared to its previous close of $47.90. During today's trading session, First Tracks Biotherapeutics, Inc.'s share price traded between $48.69 and $50.36, with an average price of $49.52. Over the past 52 weeks, the stock has recorded a high of $50.36 and a low of $14.98. In terms of performance, First Tracks Biotherapeutics, Inc.'s share price has risen by 212.06% over the last six months and is up 112.31% on a year-on-year basis.
First Tracks Biotherapeutics, Inc. Share Price Chart
First Tracks Biotherapeutics, Inc. Quarterly Profit & Loss
All figures in USD
About First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.
First Tracks Biotherapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $45.66 | $49.78 | +10.22% |
Oct 2026 | $36.02 | $45.16 | +27.33% |
Sep 2026 | $41.48 | $35.47 | -20.74% |
Aug 2026 | $44.46 | $44.75 | +1.50% |
Jul 2026 | $19.98 | $44.09 | +118.92% |
Jun 2026 | $15.87 | $20.14 | +26.51% |
May 2026 | $23.97 | $15.92 | -31.97% |
Apr 2026 | $17.00 | $23.40 | N/A |